Condition
Urodynamic Stress Incontinence
Total Trials
6
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed5
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07542080Not ApplicableRecruiting
Impact of CMG vs VCMG in Recurrent Stress Incontinence- A Pilot Study
NCT06783699CompletedPrimary
Comparison Between Positive and Negative sUPP
NCT05205395CompletedPrimary
Relationship Between Q-tip Test and Urethral Hypermobility
NCT04978714CompletedPrimary
USI and/or DO in Women With Cystocele Before and After Cystocele Repair
NCT04109157Not ApplicableCompletedPrimary
Test-retest Reliability of 20-minute Pad Test
NCT00843908Not ApplicableCompletedPrimary
Tension Free Vaginal Tape (TVT) Versus the Miniarc Sling
Showing all 6 trials